Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Brunner, M; Thurnher, D; Heiduschka, G; Grasl, MCh; Brostjan, C; Erovic, BM.
Elevated levels of circulating endothelial progenitor cells in head and neck cancer patients.
J Surg Oncol. 2008; 98(7):545-550
Doi: 10.1002/jso.21139
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Brunner Markus
- Co-authors Med Uni Graz
-
Thurnher Dietmar
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Measurement of circulating endothelial cells (CECs) and progenitor cells (EPCs) has potential as a surrogate marker for monitoring anticancer treatment. This study evaluated the significance of CECs and EPCs in the blood of patients with head and neck squamous cell carcinoma.
In a prospective trial fresh blood samples from 22 tumor patients and 18 controls were tested using multiparametric flow-cytometry. CECs were defined as CD31(+)/CD146(+) and CD45(-)/7AAD(-). EPCs were defined as CD133(+)/KDR(+) and CD3(-)/CD19(-)/CD33(-)/7AAD(-).
Median levels (min/max) of CECs in the tumor group were 2 (0/5) at the time of diagnosis, 1 (0/5) 1 year after therapy and 2 (0/6) in the control cohort. Median levels of EPCs were 5 (1/41) before and 10 (0/21) after treatment in the tumor group compared to 2 (0/7) in the control cohort (P < 0.001 and P = 0.03). CEC and EPC levels showed no apparent correlation with tumor size and response to radiotherapy after 18 months of observation.
In this pilot study CD133(+)/KDR(+) EPCs were significantly elevated in head and neck tumor patients before and after therapy. Our results warrant further studies on the use of EPCs as a surrogate marker for anticancer therapies in these patients.
(c) 2008 Wiley-Liss, Inc.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Aged -
-
Aged, 80 and over -
-
Antigens - metabolism
-
Biomarkers, Tumor - blood
-
Carcinoma, Squamous Cell - blood
-
Carcinoma, Squamous Cell - mortality
-
Carcinoma, Squamous Cell - therapy
-
Case-Control Studies -
-
Endothelial Cells - metabolism
-
Female -
-
Flow Cytometry -
-
Head and Neck Neoplasms - blood
-
Head and Neck Neoplasms - mortality
-
Head and Neck Neoplasms - therapy
-
Humans -
-
Male -
-
Middle Aged -
-
Pilot Projects -
-
Prospective Studies -
-
Stem Cells - metabolism
-
Vascular Endothelial Growth Factor Receptor-2 - metabolism
- Find related publications in this database (Keywords)
-
HNSCC
-
endothelial progenitor cells
-
neovascularisation